Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Generic Injectables Market: By Application: Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular; By Container: Vials, Ampoules, Premix; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Generic Injectables Market Outlook
The global generic injectables market size was nearly USD 32 billion in 2020. The market is further expected to grow at a CAGR of 9% in the forecast period of 2022-2027 to attain USD 54 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global generic injectables market is being driven by the growing prevalence of cancer, cardiovascular, and other diseases across the globe, coupled with rising demand for such drugs to assist patients undergoing chemotherapy, alleviating after-effects, including pain. The oncology segment, among other applications, dominates the industry, occupying a significant share. Among various distribution channels, hospitals account for the largest market share.
Region-wise, North America is the leading market, accounting for over a half of the total share. The growth of the global generic injectables market in the region can be attributed to the availability of advanced technology and enhanced healthcare infrastructure. On the other hand, the Asia Pacific is expected to be one of the emerging markets owing to the increased government expenditure in the healthcare sector in the region coupled with the presence of large population.
Properties and Applications
Generic injectables refer to the injectables that are bioequivalent of their branded counterparts and are not protected by drug patents. They are similar to original drugs and are safe and effective. They comprise of similar active ingredients, dosage, quality, and strength as their original counterparts, and, thus, their performance, intended use, quality, form, and route of administration are similar to that of their original counterparts.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on applications, the industry is divided into:
- Oncology
- Anaesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular
- Others
On the basis of containers, the industry is categorised into:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
- Others
On the basis of distribution channel, the industry can be further segmented into:
- Hospitals
- Retail Pharmacy
The report further analyses the regional markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The global generic injectables market is driven by the growing prevalence of chronic, lethal, as well as lifestyle diseases across the globe, coupled with high costs associated with their treatment. These drugs are bioequivalent of and are used as an alternative means to brand-name medicines, providing similar pharmacological effects in the treatment of various diseases. With the rise in the number of patients, the use of generic injectables is growing as they save time and provide a quick relief by getting injected directly into the bloodstream.
Although the production of generic injectables is complex, their research and development investment is cheaper and takes less time. Unlike branded drug manufacturers, generic drug manufacturers need not invest heavily in the manufacturing and marketing of their products. The sudden increase in the overall healthcare costs has boosted the demand for these injectables. Further, the growing preference of generic oncology drugs for treating cancer patients is also contributing to the global generic injectables market. Rising geriatric population and growing demand for cost-effective treatment procedures, particularly in emerging regions are aiding the industry further.
Additionally, an increase in the shortage of drugs, especially in the United States, along with patent expiry of a number of useful and famous drugs, is, in turn, boosting the global generic injectables market. The growing research and development activities are aiding the market growth. Moreover, to satisfy the growing consumer demand, the leading players in the market are innovating and launching enhanced products. The development of the latest formulations by manufacturers is expected to have a positive effect on the global generic injectables market over the forecast period.
Competitive Landscape
The report gives a detailed analysis of the following key players in the global generic injectables market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Fresenius Kabi
- Hikma Pharmaceuticals PLC
- Sagent Pharmaceuticals, Inc.
- Sanofi
- Sandoz (Novartis)
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, Container, Distribution Channel, Region |
| Breakup by Application | Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular, Others |
| Breakup by Container | Vials, Ampoules, Premix, Prefilled Syringes, Others |
| Breakup by Distribution Channel | Hospitals, Retail Pharmacy |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Fresenius Kabi, Hikma Pharmaceuticals PLC, Sagent Pharmaceuticals, Inc., Sanofi, Sandoz (Novartis), Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Generic Drugs Market Overview
8.1 Key Industry Highlights
8.2 Global Generic Drugs Historical Market (2017-2021)
8.3 Global Generic Drugs Market Forecast (2022-2027)
8.4 Global Generic Drugs Market by Region
8.4.1 Market Share
8.4.1.1 North America
8.4.1.2 Europe
8.4.1.3 Asia Pacific
8.4.1.4 Latin America
8.4.1.5 Middle East and Africa
9 Global Generic Injectables Market Analysis
9.1 Key Industry Highlights
9.2 Global Generic Injectables Historical Market (2017-2021)
9.3 Global Generic Injectables Market Forecast (2022-2027)
9.4 Global Generic Injectables Market by Application
9.4.1 Oncology
9.4.1.1 Market Share
9.4.1.2 Historical Trend (2017-2021)
9.4.1.3 Forecast Trend (2022-2027)
9.4.2 Anaesthesia
9.4.2.1 Market Share
9.4.2.2 Historical Trend (2017-2021)
9.4.2.3 Forecast Trend (2022-2027)
9.4.3 Anti-Infectives
9.4.3.1 Market Share
9.4.3.2 Historical Trend (2017-2021)
9.4.3.3 Forecast Trend (2022-2027)
9.4.4 Parenteral Nutrition
9.4.4.1 Market Share
9.4.4.2 Historical Trend (2017-2021)
9.4.4.3 Forecast Trend (2022-2027)
9.4.5 Cardiovascular
9.4.5.1 Market Share
9.4.5.2 Historical Trend (2017-2021)
9.4.5.3 Forecast Trend (2022-2027)
9.4.6 Others
9.5 Global Generic Injectables Market by Container
9.5.1 Vials
9.5.1.1 Market Share
9.5.1.2 Historical Trend (2017-2021)
9.5.1.3 Forecast Trend (2022-2027)
9.5.2 Ampoules
9.5.2.1 Market Share
9.5.2.2 Historical Trend (2017-2021)
9.5.2.3 Forecast Trend (2022-2027)
9.5.3 Premix
9.5.3.1 Market Share
9.5.3.2 Historical Trend (2017-2021)
9.5.3.3 Forecast Trend (2022-2027)
9.5.4 Prefilled Syringes
9.5.4.1 Market Share
9.5.4.2 Historical Trend (2017-2021)
9.5.4.3 Forecast Trend (2022-2027)
9.5.5 Others
9.6 Global Generic Injectables Market by Distribution Channel
9.6.1 Hospitals
9.6.1.1 Market Share
9.6.1.2 Historical Trend (2017-2021)
9.6.1.3 Forecast Trend (2022-2027)
9.6.2 Retail Pharmacy
9.6.2.1 Market Share
9.6.2.2 Historical Trend (2017-2021)
9.6.2.3 Forecast Trend (2022-2027)
9.7 Global Generic Injectables Market by Region
9.7.1 Market Share
9.7.1.1 North America
9.7.1.2 Europe
9.7.1.3 Asia Pacific
9.7.1.4 Latin America
9.7.1.5 Middle East and Africa
10 Regional Analysis
10.1 North America
10.1.1 Historical Trend (2017-2021)
10.1.2 Forecast Trend (2022-2027)
10.1.3 Breakup by Country
10.1.3.1 United States of America
10.1.3.2 Canada
10.2 Europe
10.2.1 Historical Trend (2017-2021)
10.2.2 Forecast Trend (2022-2027)
10.2.3 Breakup by Country
10.2.3.1 United Kingdom
10.2.3.2 Germany
10.2.3.3 France
10.2.3.4 Italy
10.2.3.5 Others
10.3 Asia Pacific
10.3.1 Historical Trend (2017-2021)
10.3.2 Forecast Trend (2022-2027)
10.3.3 Breakup by Country
10.3.3.1 China
10.3.3.2 Japan
10.3.3.3 India
10.3.3.4 ASEAN
10.3.3.5 Australia
10.3.3.6 Others
10.4 Latin America
10.4.1 Historical Trend (2017-2021)
10.4.2 Forecast Trend (2022-2027)
10.4.3 Breakup by Country
10.4.3.1 Brazil
10.4.3.2 Argentina
10.4.3.3 Mexico
10.4.3.4 Others
10.5 Middle East and Africa
10.5.1 Historical Trend (2017-2021)
10.5.2 Forecast Trend (2022-2027)
10.5.3 Breakup by Country
10.5.3.1 Saudi Arabia
10.5.3.2 United Arab Emirates
10.5.3.3 Nigeria
10.5.3.4 South Africa
10.5.3.5 Others
11 Market Dynamics
11.1 SWOT Analysis
11.1.1 Strengths
11.1.2 Weaknesses
11.1.3 Opportunities
11.1.4 Threats
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyer’s Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 EMR’s Key Indicators for Demand
11.4 EMR’s Key Indicators for Price
12 Value Chain Analysis
13 Project Economics
13.1 Capital Cost of the Project
13.2 Techno-Economic Parameters
13.3 Product Pricing and Margins Across Various Levels of the Supply Chain
13.4 Taxation and Depreciation
13.5 Income Projections
13.6 Expenditure Projections
13.7 Financial Analysis
13.8 Profit Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Company Profiles
14.3.1 Fresenius Kabi
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Demographic Reach and Achievements
14.3.1.4 Certifications
14.3.2 Hikma Pharmaceuticals PLC
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Demographic Reach and Achievements
14.3.2.4 Certifications
14.3.3 Sagent Pharmaceuticals, Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Demographic Reach and Achievements
14.3.3.4 Certifications
14.3.4 Sanofi
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Demographic Reach and Achievements
14.3.4.4 Certifications
14.3.5 Sandoz (Novartis)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Demographic Reach and Achievements
14.3.5.4 Certifications
14.3.6 Others
15 Industry Events and Developments
List of Figures and Tables
1. Global Generic Drugs Market: Key Industry Highlights, 2016 and 2026
2. Global Generic Drugs Historical Market: Breakup by Region (USD Billion), 2017-2021
3. Global Generic Drugs Market Forecast: Breakup by Region (USD Billion), 2022-2027
4. Global Generic Injectables Market: Key Industry Highlights, 2016 and 2026
5. Global Generic Injectables Historical Market: Breakup by Application (USD Billion), 2017-2021
6. Global Generic Injectables Market Forecast: Breakup by Application (USD Billion), 2022-2027
7. Global Generic Injectables Historical Market: Breakup by Container (USD Billion), 2017-2021
8. Global Generic Injectables Market Forecast: Breakup by Container (USD Billion), 2022-2027
9. Global Generic Injectables Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
10. Global Generic Injectables Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
11. Global Generic Injectables Historical Market: Breakup by Region (USD Billion), 2017-2021
12. Global Generic Injectables Market Forecast: Breakup by Region (USD Billion), 2022-2027
13. North America Generic Injectables Historical Market: Breakup by Country (USD Billion), 2017-2021
14. North America Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2022-2027
15. Europe Generic Injectables Historical Market: Breakup by Country (USD Billion), 2017-2021
16. Europe Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2022-2027
17. Asia Pacific Generic Injectables Historical Market: Breakup by Country (USD Billion), 2017-2021
18. Asia Pacific Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2022-2027
19. Latin America Generic Injectables Historical Market: Breakup by Country (USD Billion), 2017-2021
20. Latin America Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2022-2027
21. Middle East and Africa Generic Injectables Historical Market: Breakup by Country (USD Billion), 2017-2021
22. Middle East and Africa Generic Injectables Market Forecast: Breakup by Country (USD Billion), 2022-2027
23. Global Generic Injectables Market Structure
Key Questions Answered in the Report
The global generic injectables market reached a value of USD 32 billion in 2020.
The market is projected to grow at a CAGR of nearly 9% in the forecast period of 2022-2027.
The market is estimated to reach a value of about USD 54 billion by 2026.
The major drivers of the industry include rising disposable incomes, increasing population, rising prevalence of chronic, lethal, and lifestyle diseases, and sudden increase in the overall healthcare costs.
The development of the latest formulations by manufacturers is expected to be a key trend guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.
The oncology segment is the dominant application sector of the product in the market.
The major containers used in the industry can be divided into vials, ampoules, premix, and prefilled syringes, among others.
The hospitals segment accounts for the largest market share, among other distribution channels in the industry.
The leading players in the market are Fresenius Kabi, Hikma Pharmaceuticals PLC, Sagent Pharmaceuticals, Inc., Sanofi, and Sandoz (Novartis), among others.
Analyst Review
The global generic injectables market attained a value of USD 32 billion in 2020, driven by the growth in the overall healthcare costs. Aided by the rising geriatric population and the growing demand for cost-effective treatment procedures, the industry is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 9%. The industry is projected to reach USD 54 billion by 2026.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its applications, the global market can be segmented into oncology, anaesthesia, anti-infectives, parenteral nutrition, and cardiovascular, among others, with oncology accounting for the largest market share. By containers, the industry can be segmented into vials, ampoules, premix, and prefilled syringes, among others. On the basis of distribution channel, hospitals account for the largest share in the global industry. The major regional markets are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include Fresenius Kabi, Hikma Pharmaceuticals PLC, Sagent Pharmaceuticals, Inc., Sanofi, and Sandoz (Novartis), among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global vaccine market attained a value of nearly USD 57.55 billion in 2021, driven by the rising prevalence of chronic illnesses worldwide. Aided by the growing investments in the pharmaceutical i...
The global immunotherapy drugs market attained a value of nearly USD 179.6 billion in 2021, driven by the rising prevalence of cancer and other chronic illnesses worldwide. Aided by the growing invest...
The global anisole market attained a value of about USD 94.09 million in 2021, driven by the rising application of anisole in the pharmaceutical industry. Aided by the thriving e-commerce industry, th...
The global antiviral drugs market attained a value of more than USD 62.7 billion in 2021, driven by the rising cases of viral infections among the geriatrics, and rising healthcare expenditure. The ma...
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing...
NEWSLETTER